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Introduction
Genome integrity is constantly challenged by DNA damage,   
resulting from a range of genotoxic insults. DNA double-strand 
breaks (DSBs) represent the most toxic chromosomal lesion, 
arising from a variety of sources such as ionizing radiation (IR) 
or collapsed replication forks. To counteract the potentially   
deleterious effects of DSBs, cells have evolved homologous   
recombination (HR)–based repair mechanisms capable of re-
storing genomic integrity in an error-free manner and that rely 
on the availability of an undamaged homologous sister chroma-
tid as a template for the repair process.
A key event in HR repair is the formation of a nucleofilament 
of the rate-limiting recombinase Rad51, wrapped around single-
stranded DNA (ssDNA) generated in the vicinity of the DSB (San 
Filippo et al., 2008). The Rad51/ssDNA nucleofilament catalyzes 
a search for a homologous sequence on the sister chromatid and 
promotes DNA strand invasion to initiate the repair process.   
Despite its importance for preserving genomic integrity, HR repair 
must be tightly controlled. Unrestricted HR activity is a hallmark 
of genetic disorders such as Bloom (BLM) and Werner syndromes, 
both of which display a hyper-recombination phenotype and ge-
nomic instability (Sung and Klein, 2006; Branzei and Foiani, 2007). 
To restrict HR, cells harbor proteins termed anti-recombinases. In 
budding yeast, the Srs2 helicase has such a function, preventing 
spontaneous and unscheduled HR by dismantling Rad51 from   
ssDNA (Krejci et al., 2003; Veaute et al., 2003). In humans, the 
genes mutated in BLM, Werner, and Rothmund-Thomson 
(RecQL4) syndromes also encode helicases belonging to the 
RecQ family, all of which exhibit anti-recombinase activity (Wu 
and Hickson, 2006). BLM dissociates Rad51/ssDNA nucleofila-
ments, thereby suppressing HR, a function that was also reported 
for the helicase RecQL5 (Bugreev et al., 2007; Hu et al., 2007).
  H
omologous  recombination  (HR)  is  essential  for 
faithful repair of DNA lesions yet must be kept in 
check, as unrestrained HR may compromise ge-
nome integrity and lead to premature aging or cancer. To 
limit unscheduled HR, cells possess DNA helicases capa-
ble of preventing excessive recombination. In this study, 
we show that the human Fbh1 (hFbh1) helicase accumu-
lates at sites of DNA damage or replication stress in a 
manner dependent fully on its helicase activity and par-
tially on its conserved F box. hFbh1 interacted with single-
stranded  DNA  (ssDNA),  the  formation  of  which  was 
required  for  hFbh1  recruitment  to  DNA  lesions.  Con-
versely, depletion of endogenous Fbh1 or ectopic expres-
sion  of  helicase-deficient  hFbh1  attenuated  ssDNA 
production  after  replication  block.  Although  elevated   
levels of hFbh1 impaired Rad51 recruitment to ssDNA 
and suppressed HR, its small interfering RNA–mediated 
depletion  increased  the  levels  of  chromatin-associated 
Rad51 and caused unscheduled sister chromatid exchange. 
Thus, by possessing both pro- and anti-recombinogenic 
potential, hFbh1 may cooperate with other DNA helicases 
in tightly controlling cellular HR activity.
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the kinetics of GFP-hFbh1 focus formation paralleled that of RPA, 
becoming apparent 30 min after exposure to the drug (Fig. 1 C). 
Similar kinetics of GFP-hFbh1 recruitment was observed in   
response to IR (Fig. S1 B). These observations suggest that   
hFbh1 is a novel factor involved in the DNA damage response in 
human cells, functioning at an advanced stage associated with   
ssDNA formation.
hFbh1 interacts with ssDNA
The recruitment of RecQ helicases to DNA lesions can be highly 
dependent on specific DNA structures produced during the pro-
cess of HR (Wu and Hickson, 2006). To investigate the require-
ments for hFbh1 recruitment to DNA lesions, we first assessed 
the impact of depleting different proteins involved in processing 
damaged DNA. Knockdown of CtIP, a factor required for resec-
tion of DSBs into ssDNA (Sartori et al., 2007), severely im-
paired GFP-hFbh1 focus formation in response to IR but not HU 
(Fig. 2 A), which generates ssDNA independent of resection. 
This suggested that hFbh1 is recruited to ssDNA but not unpro-
cessed DSBs. To determine whether hFbh1 recruitment to dam-
aged DNA required DNA intermediates produced after strand 
invasion during HR, we depleted Rad51 or Rad51C, a Rad51 
mediator essential for Rad51 focus formation after DNA dam-
age (Rodrigue et al., 2006). Although the Rad51 and Rad51C 
siRNAs depleted their targets (Fig. 2 A), such treatments did not 
interfere with GFP-hFbh1 recruitment in response to either IR 
or HU (Fig. 2 A), suggesting that hFbh1 is directly recruited to 
ssDNA rather than recombination intermediates.
To test the idea that hFbh1 recognizes ssDNA, cells were 
prelabeled with BrdU before exposure to HU and subjected to 
immunostaining under nondenaturing conditions in which BrdU 
is only detectable in ssDNA regions (Groth et al., 2007). Under 
these conditions, GFP-hFbh1 completely colocalized with the 
BrdU-decorated ssDNA compartment (Fig. 2 B), supporting the 
notion that hFbh1 associates with ssDNA. To see whether hFbh1 
directly  binds  ssDNA,  we  performed  electrophoretic  mobility 
shift assays (EMSAs) in which purified GST-hFbh1 was incu-
bated with ssDNA or double-stranded DNA (dsDNA) probes. As 
shown in Fig. 2 C, hFbh1 bound to ssDNA but not to dsDNA.   
Although hFbh1 recruitment to ssDNA regions generated by IR was 
restricted to S and G2 phases, we observed that GFP-hFbh1 ac-
cumulated at UV-damaged DNA in a subset of cyclin A–negative 
cells (Fig. S2 A). However, we failed to detect accumulation of 
GFP-Fbh1 at UV lesions in early G1 cells after mitotic shake off 
(Fig. S2 B). We conclude from these experiments that hFbh1 may 
be recruited to ssDNA produced in late G1 but not in early G1.
hFbh1 displaces Rad51 from chromatin to 
suppress HR
Evidence from yeast and other organisms suggests that Srs2 and 
the RecQ helicases possess anti-recombinogenic activities by 
dismantling the Rad51 nucleofilament from ssDNA produced 
during normal replication (Sung and Klein, 2006). We tested 
whether hFbh1 might similarly prevent Rad51 focus forma-
tion after a replication block using the inducible GFP-hFbh1 
cell line. As expected, Rad51 readily accumulated in nuclear 
foci when uninduced cells were treated with HU or IR (Fig. 3 A).   
The  existence  of  several  helicases  with  anti-recombino-
genic  properties  in  mammalian  cells  suggests  a  consider-
able degree of complexity and redundancy in HR regulation. 
Recently, a functional homologue of Saccharomyces cerevisiae 
Srs2, RTEL1, was identified in humans (Barber et al., 2008). 
Fbh1, another conserved helicase with similarity to Srs2, has 
also been proposed to be a functional homologue of Srs2 in 
fission yeast and higher eukaryotes (Chiolo et al., 2007), but 
so far little is known about the function of Fbh1. Fbh1 belongs   
to the UvrD family of helicases and has 3–5 DNA-unwinding   
activity (Kim et al., 2004). Moreover, Fbh1 is a putative E3 
ubiquitin ligase by virtue of a conserved F box, enabling it to 
potentially function as an adaptor for the Skp, Cullin, F box–
containing complex (Kim et al., 2004). However, at present, its 
ubiquitylation  targets  are  unknown.  In  Schizosaccharomyces 
pombe, Fbh1 knockout leads to increased sensitivity to DNA-
damaging agents (Morishita et al., 2005; Osman et al., 2005). 
Chicken DT40 cells ablated for Fbh1 exhibit an overall mild 
phenotype yet display an elevated rate of sister chromatid ex-
change (SCE), which is a phenomenon associated with hyper 
recombination (Kohzaki et al., 2007). In these cells, Fbh1 acts 
redundantly with BLM, and their codisruption causes a syner-
gistic increase in DNA damage sensitivity.
In this study, we have performed a detailed analysis of the 
functional properties of Fbh1 in human cells. We show that human 
Fbh1 (hFbh1) possesses both pro- and anti-recombinogenic   
activities, contributing to the regulation of ssDNA production at 
replication blocks as well as regulation of Rad51 nucleofilament 
formation and HR repair. Our findings reveal evolutionary con-
servancy of Fbh1 function and broaden the spectrum of anti- 
recombinogenic helicases in mammalian cells.
Results and discussion
hFbh1 accumulates at sites of  
DNA damage
To investigate whether Fbh1 plays a role in the DNA damage 
response in human cells, we examined the impact of DNA- 
damaging insults on the subcellular localization of hFbh1. Be-
cause high levels of hFbh1 appeared toxic to cells (unpublished 
data), we generated a U2OS cell line stably expressing GFP-
tagged hFbh1 in a doxycycline (DOX)-inducible fashion at low 
levels, which did not detectably interfere with cell proliferation 
(Fig. S1 A). In this cell line, GFP-hFbh1 showed uniform nu-
clear staining upon induction in the absence of exogenous DNA 
damage (Fig. 1 A). However, in response to DSBs generated by 
IR or laser microirradiation or replication blocks elicited by 
treatment with hydroxyurea (HU), GFP-hFbh1 accumulated in 
discrete subnuclear foci (Fig. 1 A), which is similar to the be-
havior of a range of DNA damage–responsive proteins. The 
GFP-hFbh1 foci completely colocalized with the ssDNA-binding 
protein replication protein A (RPA) but only partially over-
lapped with -H2AX, a marker for DSBs (Fig. 1 A). The forma-
tion of GFP-hFbh1 foci in response to IR was restricted to S and 
G2 phases, the cell cycle stages permissive for HR, as their for-
mation occurred only in cyclin A–positive cells and included 
BrdU-incorporating S phase cells (Fig. 1 B). In response to HU, 657 REGULATION OF HOMOLOGOUS RECOMBINATION BY hFbh1 • Fugger et al.
Figure 1.  hFbh1 accumulates at sites of DNA damage in S and G2 phase cells. (A) U2OS/GFP-hFbh1 WT cells were induced to express GFP-hFbh1 by 
addition of DOX for 24 h, and were subsequently left untreated or subjected to laser microirradiation, IR (6 Gy), or HU treatment. 1 h later, the cells were 
fixed and coimmunostained with antibodies to RPA and -H2AX. Magnifications of HU- and IR-treated cells are shown (red lines). (B) U2OS/GFP-hFbh1 
WT cells induced to express the transgene for 24 h were subjected to IR (6 Gy) for 1 h, pulsed with BrdU for 20 min, and fixed and coimmunostained with 
the indicated antibodies. (C) U2OS/GFP-hFbh1 WT cells induced with DOX for 24 h were incubated in the presence of HU for the indicated times and 
processed for immunofluorescence as in A. Bars, 10 µm.JCB • VOLUME 186 • NUMBER 5 • 2009   658
formation by targeting it for proteasomal degradation. Unlike 
total levels of Rad51, cellular fractionation experiments demon-
strated that the HU-dependent increase in chromatin-associated 
Rad51 was suppressed by induction of GFP-hFbh1 (Fig. 3 B). 
Moreover, GFP-hFbh1 led to an increase in chromatin-bound 
RPA after HU treatment (Fig. 3 A), indicating that the ability 
of GFP-hFbh1 to prevent Rad51 accumulation at DNA damage 
sites did not reflect a general propensity to displace ssDNA-
binding proteins. These data indicate that hFbh1 or an hFbh1-
containing complex is capable of actively removing Rad51 
from chromatin.
Because  ectopic  GFP-hFbh1  can  displace  Rad51  from 
chromatin, we speculated that depletion of endogenous hFbh1 
would lead to chromatin retention of Rad51 during replication. 
To test this, we assessed Rad51 focus formation in primary BJ 
fibroblasts transfected with hFbh1 siRNAs. Using the nucleo-
side analogue EdU as a marker for replicating cells, we analyzed 
Rad51 focus formation in S phase and observed a significant, 
roughly threefold increase in the occurrence of spontaneous 
Rad51 foci in cells depleted for endogenous hFbh1 using two 
independent siRNAs (Fig. 3 C). To directly test whether hFbh1 
has anti-recombinase activity, we used an HR reporter assay in 
which HR is measured as the ability of cells to repair an I-SceI–
induced DSB in an inactive GFP construct that becomes func-
tional only through HR-mediated repair (Sartori et al., 2007). 
We observed a marked 40% decrease in HR events when 
hFbh1 was cotransfected with I-SceI (Fig. 3 D), which is com-
parable with the extent of HR suppression observed after siRNA-
mediated depletion of Rad51 (not depicted). Collectively,   
these findings suggest that hFbh1 functions as a bonafide anti-
recombination factor in human cells through its ability to dis-
mantle the Rad51 nucleofilament and thus may help to prevent 
unscheduled HR during normal DNA replication and in re-
sponse to DNA damage.
hFbh1 facilitates ssDNA generation at 
stalled replication forks
To further dissect the mechanism by which hFbh1 displaces Rad51 
from chromatin, we introduced point mutations into hFbh1 to 
functionally impair its conserved F box (Fig. 4 A, *FB) or helicase 
domains (Fig. 4 A, *HL). We verified the effect of the F box muta-
tions by demonstrating that they impaired hFbh1 binding to the 
Skp, Cullin, F Box–containing complex core subunit Skp1, which 
is the known function of the F box (Fig. S1 C). Surprisingly, hFbh1 
helicase domain was also unable to bind Skp1 (Fig. S1 C), which 
may suggest that hFbh1 only associates stably with Skp1 in a 
chromatin context (see following paragraph). In agreement with 
data from fission yeast (Sakaguchi et al., 2008), mutation of the   
F box resulted in pancellular distribution of GFP-hFbh1 (unpub-
lished data), and thus, we tagged the GFP-hFbh1 constructs with 
N-terminal NLSs to be able to compare their functional properties. 
We generated stable cell lines expressing such NLS–GFP-hFbh1 
proteins and tested their ability to recruit to ssDNA regions in-
duced by HU treatment. Although mutation of the F box partially 
impaired the binding of GFP-hFbh1 to RPA-coated ssDNA, dis-
ruption of the catalytic activity of its helicase domain completely 
prevented accumulation of GFP-hFbh1 on ssDNA (Fig. 4 B).
Strikingly, however, induction of GFP-hFbh1 in these cells 
strongly impaired Rad51 foci formation in response to HU and 
IR (Fig. 3 A). Expression of Rad51 was unaffected by induc-
tion of GFP-hFbh1 (Fig. 3 B), arguing against the possibility 
that hFbh1, a potential E3 ubiquitin ligase, inhibits Rad51 focus 
Figure 2.  hFbh1 interacts with ssDNA. (A) U2OS/GFP-hFbh1 WT cells 
were transfected with the indicated siRNAs for 24 h, induced with DOX 
for an additional 24 h, and exposed to IR or HU for 1 h. (top) The cells 
were fixed, and the GFP signal was visualized by confocal microscopy. 
(bottom) Immunoblot analysis of siRNA-mediated knockdown efficiency. 
(B) U2OS/GFP-hFbh1 WT cells were incubated in the presence of BrdU 
and DOX for 24 h. The cells were treated with HU for 1 h, fixed, and 
immunostained with BrdU antibody under native conditions. (C) EMSA is 
shown. 
32P-labeled ssDNA or dsDNA probes were incubated with increas-
ing amounts (200–1,000 nM) of GST-hFbh1 and subjected to native gel 
electrophoresis. Migration of the probe and the GST-hFbh1–ssDNA com-
plex is indicated. Bars, 10 µm.659 REGULATION OF HOMOLOGOUS RECOMBINATION BY hFbh1 • Fugger et al.
Figure 3.  hFbh1 acts as an anti-recombinase by displacing Rad51 from chromatin. (A) U2OS/GFP-hFbh1 WT cells were induced or not with DOX for 
24 h and subjected to HU for 2 h or IR for 1 h. (left) The cells were preextracted to remove soluble proteins, fixed, and coimmunostained with RPA and 
Rad51 antibodies. (right) Quantification of the results of three independent experiments is shown. (B) U2OS/GFP-hFbh1 WT cells subjected to DOX 
and HU treatment as in A were harvested and processed for subcellular fractionation. Chromatin-enriched fractions and whole cell extracts (WCE) were 
immunoblotted with the indicated antibodies. Relative intensity of the Rad51 signal is indicated. (C) BJ fibroblasts were transfected with control or two 
independent hFbh1 siRNAs for 48 h. (top) Cells were incubated with EdU for 30 min, preextracted, fixed, and immunostained with Rad51 antibody and 
EdU. Two representative fields from each transfected population are shown. (bottom) The intensity of chromatin-bound Rad51 staining was quantified 
by image analysis software and depicted in a box plot. SID, signal-integrated density. At least 50 EdU-positive cells were analyzed in each experiment.   
(D) U2OS/DR-GFP cells were transfected with plasmids encoding RFP, I-SceI, and, where indicated, empty vector or Flag-hFbh1 for 48 h. Cells were pro-
cessed for flow cytometric analysis of RFP and GFP, and the extent of HR was scored as the GFP/RFP ratio. The experiment was performed in triplicates. 
Error bars indicate the standard deviation. Bars, 10 µm.JCB • VOLUME 186 • NUMBER 5 • 2009   660
Figure 4.  The helicase activity of hFbh1 facilitates ssDNA generation at replication blocks. (A) Schematic depiction of the hFbh1 protein, showing localiza-
tion of conserved domains. Positions of residues mutated to generate hFbh1 F box (*FB) and helicase domain (*HL) mutants are indicated in red.   
(B) U2OS/NLS–GFP-hFbh1 cell lines were induced or not with DOX for 24 h, treated with HU for 1 h, and fixed. Where indicated, cells were preextracted 
before fixation. The cells were coimmunostained with the indicated antibodies. (C) U2OS/NLS–GFP-hFbh1 cell lines were treated with DOX and HU as in 
B and processed for subcellular fractionation. Chromatin-enriched fractions (CHR) or whole cell extracts (WCE) were immunoblotted with the indicated anti-
bodies. (D) U2OS/GFP-hFbh1 cells were transfected with control or hFbh1 siRNA for 48 h and incubated in the presence of BrdU for an additional 24 h. 
Cells transfected with hFbh1 siRNA were either left uninduced or induced with DOX for the last 24 h. Cells were treated with HU for 2 h and processed for 
native fixation and immunostaining with BrdU antibody. BrdU staining was quantified by image analysis software and depicted in a box plot. SID, signal-
integrated density. At least 1,000 cells were analyzed in each experiment. Bars, 10 µm.661 REGULATION OF HOMOLOGOUS RECOMBINATION BY hFbh1 • Fugger et al.
dominant-negative factor to prevent further ssDNA production in 
response to replication blocks, likely blocking the access of ac-
tive Fhh1 (and perhaps even other ssDNA-producing helicases) to 
DNA lesions. As has been found for other UvrD helicases (Maluf 
et al., 2003), hFbh1 formed homodimers (Fig. S2 D), potentially 
explaining the ability of the overexpressed helicase domain mutant 
to act in a dominant-negative fashion in the presence of endoge-
nous hFbh1. Thus, the lack of Rad51 focus formation observed in 
HU-treated cells expressing GFP-Fbh1 helicase domains (Fig. 4 B) 
likely reflects their inability to produce sufficiently long stretches 
of ssDNA required for Rad51 recruitment.
Collectively, these data suggest that in addition to its anti-
recombinogenic effect, hFbh1 may also possess prorecombi-
nase activity by facilitating ssDNA production after replication 
blocks to promote the loading of RPA, which is in turn required 
for proper checkpoint signaling and HR repair. Consistently, 
cells depleted for endogenous hFbh1 displayed markedly re-
duced ssDNA production in response to HU treatment, an effect 
that could be fully rescued by induction of siRNA-insensitive 
GFP-Fbh1 in these cells (Fig. 4 D). Such a dual role of hFbh1 in 
terms of pro- and anti-recombination activities is analogous to 
that of BLM helicase, which functions in ssDNA production   
after DNA damage (Gravel et al., 2008; Zhu et al., 2008) as well 
as displacement of Rad51 from ssDNA (Bugreev et al., 2007).
hFbh1 is a suppressor of SCE
A prominent feature of unrestricted HR is the hyper-recombination 
phenotype, a hallmark of BLM syndrome, which is characterized 
Surprisingly, overexpression of both F box and helicase do-
main mutants was still able to prevent accumulation of Rad51 at 
the sites of stalled replication forks (Fig. 4 B). In case of the F box 
mutant, this can be explained, at least in part, by its residual capa-
bility to bind damaged DNA, which might be sufficient to displace 
Rad51 from ssDNA. Such a scenario also indicates that the po-
tential ubiquitin ligase activity of hFbh1 (the function of which is 
unknown) may not be required per se for its anti-recombinogenic 
function. The impact of the helicase domain mutant on Rad51   
focus formation appeared more complex, and to elucidate this issue, 
we set out to measure the production of ssDNA after replication 
stress. Interestingly, we observed that cells overexpressing GFP-
hFbh1 helicase domains failed to produce detectable HU-induced 
ssDNA stretches, which is indicated by a quantitative loss of RPA 
foci and reduced BrdU immunostaining under native conditions 
(Fig. 4 B). We obtained similar results using biochemical isolation 
of chromatin-enriched fractions from NLS–GFP-hFbh1–inducible 
cells in which the helicase domain mutant but not the wild-type 
(WT) or F box alleles of GFP-hFbh1 suppressed the increased 
chromatin loading of RPA after HU treatment (Fig. 4 C). Induction 
of WT or mutant GFP-hFbh1 had little impact on cell cycle dis-
tribution (Fig. S1 D), ruling out cell cycle effects as a major cause   
of the observed phenotypes. Using EMSA, we found that the 
hFbh1 helicase domain mutant retained the capability to bind to   
ssDNA (Fig. S2 C) even though it was not stably recruited to 
ssDNA sites (Fig. 4 B). Thus, it appears that by binding short 
stretches of ssDNA at stalled replication forks while being unable 
to unwind DNA, the hFbh1 helicase domain mutant may act as a 
Figure 5.  Depletion of hFbh1 increases SCE. 
(A)  BJ  cells  were  transfected  with  control  or 
hFbh1 siRNAs for 48 h and subjected to SCE 
analysis.  Metaphase  chromosome  spreads 
were prepared, and the number of SCE events 
was scored on a per cell basis and subjected 
to statistical analysis. The image shows a rep-
resentative  metaphase  chromosome  spread 
from hFbh1-depleted cells. The inset shows a 
magnification of an SCE event in the boxed   
region.  Efficiency  of  hFbh1  knockdown  is 
shown in Fig. S3. Bar, 10 µm. (B) Box plot 
showing results of the experiment in A. The 
increase  in  SCE  events  in  hFbh1-depleted 
cells was reproduced in an independent ex-
periment. At least 25 metaphase spreads were 
analyzed in each experiment. (C) SCE assay 
of cells as in B. 2.5 nM camptothecin (CPT) 
was  present  in  the  medium  throughout  the 
course of the experiment. (D) A hypothetical 
model of the pro- and anti-recombinase func-
tion of hFbh1 at stalled replication forks (left) 
and resected DSBs (right). See Materials and 
methods for further details.JCB • VOLUME 186 • NUMBER 5 • 2009   662
maintained as described previously (Mailand et al., 2007). IR (6 Gy) was 
delivered using an x-ray generator (150 kV; 15 mA; dose rate, 2.18 Gy/min; 
HF160; Pantak). To induce local UV damage, cells grown on coverslips 
were irradiated with 100 J/m
2 UV-C light in a Stratalinker (Agilent Technol-
ogies) through a polycarbonate filter with 5-µm pores (Millipore). Drugs 
used in this study included 1 µg/ml DOX (EMD), 1 mM HU (Sigma-Aldrich), 
and 10 µM BrdU (Sigma-Aldrich).
Immunochemical methods
Immunoblotting, immunoprecipitation, and immunofluorescence were per-
formed as described previously (Mailand et al., 2006). To visualize gener-
ation of ssDNA upon HU treatment, cells were preincubated with BrdU for 
24 h and subjected to BrdU immunofluorescence under nondenaturing con-
ditions. To remove soluble proteins before immunofluorescence, cells grown 
on coverslips were preextracted for 5 min with ice-cold CSK buffer (10 mM 
Pipes, pH 6.8, 300 mM sucrose, 100 mM NaCl, and 1.5 mM MgCl2) sup-
plemented with 0.5% Triton X-100 before fixation with 4% paraformalde-
hyde. To obtain chromatin-enriched cellular fractions, cells were lysed in 
CSK buffer supplemented with 0.5% Triton X-100. Cell pellets were washed 
once with CSK buffer, resuspended in 0.2 M HCl, and incubated at 4°C 
for 2 h. The supernatant represented the chromatin-enriched fraction. A 
rabbit polyclonal antibody to hFbh1 was raised against a peptide span-
ning  amino  acids  168–182  of  hFbh1  (Eurogentec).  Rabbit  polyclonal 
Rad51C antibody was provided by R. Kanaar (Erasmus Medical Center, 
Rotterdam,  Netherlands).  Other  antibodies  used  in  this  study  included 
mouse monoclonals to RPA (clone 9H8; NeoMarkers), BrdU (GE Health-
care), and Skp1 (Transduction Laboratories), rabbit polyclonals to Rad51 
(H-92; Santa Cruz Biotechnology, Inc.), -H2AX (Millipore), cyclin A   
(H-432; Santa Cruz Biotechnology, Inc.), full-length GFP (Santa Cruz Bio-
technology, Inc.), and human autoantibody to proliferating cell nuclear   
antigen (Immuno Concepts). EdU (5-ethynyl-2-deoxyuridine) labeling was 
performed by incubating cells with 10 µM EdU (Invitrogen) for 30 min fol-
lowed by fluorescent staining according to the manufacturer’s instructions.
Microscopy
Acquisition of confocal images was done essentially as described previ-
ously (Bekker-Jensen et al., 2006) using a confocal microscope (LSM 510; 
Carl Zeiss, Inc.) fitted with a PPlan Neofluar 40× NA 1.3 oil immersion 
objective (Carl Zeiss, Inc.). Laser microirradiation to generate DSBs in de-
fined nuclear volumes was performed as described previously (Bekker- 
Jensen et al., 2006). For three-color imaging, GFP signals were combined 
with  secondary  antibodies  coupled  to  AlexaFluor  dyes  with  excitation 
wavelengths of 568 and 647 mm. Image acquisition and processing were 
performed with LSM 510 software (Carl Zeiss, Inc.). Quantification of 
Rad51 foci and BrdU was performed using custom-made macro routines. 
In brief, images were acquired using a fluorescence microscope (Axio-
plan II; Carl Zeiss, Inc.) equipped with a Plan Neofluar 40× 1.3 oil immer-
sion objective. Exposure time, binning, and settings of the microscope and 
light source were kept constant for all the samples. Photoshop (Adobe) 
was used to select single cells based on either EdU (for Rad51 foci) or 
DAPI (for BrdU staining). Each selected cell was subsequently analyzed 
using ImageJ software (National Institutes of Health) to measure the signal-
integrated density of either Rad51 or BrdU staining. The numerical data 
were further processed in Excel (Microsoft) by mathematical operations, 
and  statistical  analysis  of  paired  datasets  was  performed  using  t  test 
(Prism; GraphPad Software, Inc.). The entire procedure was described 
previously in Mistrik et al. (2009).
EMSA
EMSA was performed essentially as described previously (Modesti et al., 
2007). In brief, bacterially purified GST-hFbh1 constructs were incubated 
with 
32P-labeled ssDNA or dsDNA probes (2 nM) produced by standard 
methods in binding buffer (20 mM Tris-HCl, pH 7.4, 50 mM KCl, 0.1 mg/ml 
BSA, and 2 mM DTT) at 30°C for 15 min. Samples were resolved on native 
TBE polyacrylamide gels, dried, and visualized by autoradiography. DNA 
probes used in EMSA were X0-1, 5-GACGCTGCCGAATTCTACCAGT-
GCCTTGCTAGGACATCTTTGCCCACCTGCAGGTTCACCC-3;  and  X0-1c, 
5-GGGTGAACCTGCAGGTGGGCAAAGATGTCCTAGCAAGGCACTG-
GTAGAATTCGGCAGCGTC-3.
HR assay
HR rates were measured essentially as described previously (Sartori et al., 
2007). In brief, a U2OS derivative cell line harboring an integrated HR   
reporter construct (DR-GFP) was cotransfected with plasmids expressing 
RFP, I-SceI, and, where indicated, hFbh1 for 48 h. Transfection of RFP 
by an increase in the SCE (Branzei and Foiani, 2007). The simi-
lar functions of hFbh1 and BLM prompted us to explore whether 
hFbh1 also regulates SCE. Knockdown of hFbh1 in primary fibro-
blasts led to a small but significant increase in SCE compared 
with control cells (5.6 and 4.1 events/cell, respectively; Fig. 5, 
A and B), an effect augmented by exposure to camptothecin 
(34 vs. 22 events/cell, respectively; Fig. 5 C). This is consistent 
with data in Fbh1-deficient chicken DT40 cells, which also ex-
hibit increased SCE (Kohzaki et al., 2007), and further supports 
the notion that hFbh1 is a bonafide anti-recombinogenic factor 
required to restrain unscheduled HR, slight elevations of which 
may be sufficient to compromise genomic integrity. The exis-
tence of several helicases with anti-recombinogenic functions 
in human cells may account for a higher degree of redundancy 
in this system and could explain the relatively mild SCE pheno-
type observed in hFbh1 knockdown cells.
In conclusion, our findings provide evidence that hFbh1 
functions as a regulator of HR repair in human cells and sug-
gest a model of how hFbh1 exerts such a function (Fig. 5 D). 
In the first step, hFbh1 is recruited to genotoxic stress-induced   
ssDNA. By means of its helicase activity, hFbh1 may help to 
facilitate ssDNA production to the extent required for produc-
tive HR, and up to this stage, hFbh1 can function to promote HR 
initiation. However, in later stages, hFbh1 restrains excessive 
and/or unscheduled HR through its ability to displace Rad51 
from ssDNA. Such a dual role in the multistep process of HR 
has also been proposed for the BLM helicase (Bugreev et al., 
2007). hFbh1 may increase the pool of cellular pro- and anti- 
recombinase activities and thus contributes to the maintenance 
of genomic integrity.
Materials and methods
Plasmids and RNAi
A partial cDNA spanning amino acids 126–1,094 of hFbh1 was provided 
by  Y.-S.  Seo  (Korea  Advanced  Institute  of  Science  and  Technology,   
Daejeon, Korea). The N-terminal part of hFbh1 cDNA (amino acids 1–125) 
was amplified from QUICK-Clone Human Universal cDNA (Clontech Labo-
ratories, Inc.). The full-length hFbh1 was constructed by overlapping PCR of 
these fragments and was inserted into pEGFP-C1 (Clontech Laboratories, 
Inc.). From this construct, GFP-tagged hFbh1 was amplified by PCR and 
subcloned into pcDNA4/TO (Invitrogen) to allow DOX-inducible expres-
sion of GFP-hFbh1. To enforce nuclear expression of GFP-hFbh1, GFP-
hFbh1 constructs were subcloned into pcDNA4/TO harboring three 
N-terminal NLSs from pCMV/Myc/nuc (Invitrogen). Introduction of point 
mutations to generate the F box (L278A and P279A) and helicase (D698N) 
mutants of hFbh1 (Osman et al., 2005) was performed using the Quik-
Change site-directed mutagenesis kit (Agilent Technologies). To produce 
GST-tagged hFbh1, full-length versions of WT or mutant hFbh1 were sub-
cloned into pGEX-6P1 (Invitrogen). Plasmid transfections were performed 
using FuGene6 (Roche).
The following siRNA sequences were used in this study: hFbh1#1, 
5-GAUACAGAGUGAAGAAUGU-3; hFbh1#2, 5-GGGAUGUUCUUU-
UGAUAAAUU-3; Rad51, 5-GAGCUUGACAAACUACUUC-3; Rad51C, 
5-GUUCAGCACUAGAUGAUAU-3;  CtIP,  5-GCUAAAACAGGAAC-
GAAUC-3; and control, 5-GCGCGCUUUGUAGGAUUCG-3. All siRNA 
duplexes (Thermo Fisher Scientific) were transfected at a final concentra-
tion of 100 nM using Lipofectamine RNAiMAX (Invitrogen) according to 
the manufacturer’s instructions for U2OS and BJ cells.
Cell culture
Human U2OS osteosarcoma cells and primary BJ fibroblasts were cul-
tured in DME containing 10% fetal bovine serum. U2OS derivative cell 
lines expressing NLS)GFP–tagged hFbh1 constructs in a DOX-inducible 
fashion from pcDNA4/TO-NLS–GFP-hFbh1 vectors were generated and 663 REGULATION OF HOMOLOGOUS RECOMBINATION BY hFbh1 • Fugger et al.
Mailand, N., S. Bekker-Jensen, J. Bartek, and J. Lukas. 2006. Destruction of 
Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recov-
ery from genotoxic stress. Mol. Cell. 23:307–318. 
Mailand, N., S. Bekker-Jensen, H. Faustrup, F. Melander, J. Bartek, C. Lukas, 
and J. Lukas. 2007. RNF8 ubiquitylates histones at DNA double-strand 
breaks and promotes assembly of repair proteins. Cell. 131:887–900. 
Maluf, N.K., C.J. Fischer, and T.M. Lohman. 2003. A dimer of Escherichia coli 
UvrD is the active form of the helicase in vitro. J. Mol. Biol. 325:913–935. 
Mistrik, M., L. Oplustilova, J. Lukas, and J. Bartek. 2009. Low-dose DNA dam-
age and replication stress responses quantified by optimized automated 
single-cell image analysis. Cell Cycle. 8:2592–2599. 
Modesti, M., M. Budzowska, C. Baldeyron, J.A. Demmers, R. Ghirlando, and R. 
Kanaar. 2007. RAD51AP1 is a structure-specific DNA binding protein 
that stimulates joint molecule formation during RAD51-mediated homol-
ogous recombination. Mol. Cell. 28:468–481. 
Morishita, T., F. Furukawa, C. Sakaguchi, T. Toda, A.M. Carr, H. Iwasaki, and H. 
Shinagawa. 2005. Role of the Schizosaccharomyces pombe F-Box DNA 
helicase  in  processing  recombination  intermediates.  Mol.  Cell.  Biol. 
25:8074–8083. 
Osman, F., J. Dixon, A.R. Barr, and M.C. Whitby. 2005. The F-box DNA heli-
case Fbh1 prevents Rhp51-dependent recombination without mediator 
proteins. Mol. Cell. Biol. 25:8084–8096. 
Rodrigue, A., M. Lafrance, M.C. Gauthier, D. McDonald, M. Hendzel, S.C. West, 
M. Jasin, and J.Y. Masson. 2006. Interplay between human DNA repair 
proteins at a unique double-strand break in vivo. EMBO J. 25:222–231. 
Sakaguchi, C., T. Morishita, H. Shinagawa, and T. Hishida. 2008. Essential and 
distinct roles of the F-box and helicase domains of Fbh1 in DNA damage 
repair. BMC Mol. Biol. 9:27. 
San Filippo, J., P. Sung, and H. Klein. 2008. Mechanism of eukaryotic homolo-
gous recombination. Annu. Rev. Biochem. 77:229–257. 
Sartori, A.A., C. Lukas, J. Coates, M. Mistrik, S. Fu, J. Bartek, R. Baer, J. Lukas, 
and  S.P.  Jackson.  2007.  Human  CtIP  promotes  DNA  end  resection. 
Nature. 450:509–514. 
Sung, P., and H. Klein. 2006. Mechanism of homologous recombination: media-
tors and helicases take on regulatory functions. Nat. Rev. Mol. Cell Biol. 
7:739–750. 
Veaute, X., J. Jeusset, C. Soustelle, S.C. Kowalczykowski, E. Le Cam, and F. 
Fabre.  2003. The  Srs2  helicase  prevents  recombination  by  disrupting 
Rad51 nucleoprotein filaments. Nature. 423:309–312. 
Wu, L., and I.D. Hickson. 2006. DNA helicases required for homologous recom-
bination  and  repair  of  damaged  replication  forks.  Annu.  Rev.  Genet. 
40:279–306. 
Zhu, Z., W.H. Chung, E.Y. Shim, S.E. Lee, and G. Ira. 2008. Sgs1 helicase and 
two nucleases Dna2 and Exo1 resect DNA double-strand break ends. 
Cell. 134:981–994. 
alone served as a reference for the absence of HR. Cells were collected by 
trypsinization and subjected to flow cytometric analysis of GFP and RFP. 
The extent of I-SceI–induced HR was measured as the ratio between the 
GFP and RFP signal.
SCE assay
Cells were incubated in the presence of 10 µM BrdU for 46 h, after which 
1 µg/ml colcemide (Invitrogen) was added to the medium for an additional 
2 h. Cells were harvested by trypsinization, resuspended in 75 mM KCl 
hypotonic buffer, and incubated at 37°C for 25 min. After centrifugation, 
cell pellets were incubated with fixative (75% methanol and 25% acetic 
acid) for 10 min, washed twice, and mitotic spreads were prepared by 
dropping the cell suspension in fixative on microscopy glass slides covered 
with water and allowed to air dry for at least 48 h in the dark. For chroma-
tid staining, slides were immersed in Acridine orange (0.1 mg/ml in water; 
Invitrogen) for 3 min, washed thoroughly in water, and incubated in Soren-
son buffer, pH 6.8 (0.1 M Na2HPO4 and 0.1 M NaH2PO4), for 3 min.   
Finally, slides were dried and analyzed by confocal microscopy.
Online supplemental material
Fig.  S1  shows  characterization  of  GFP-hFbh1–expressing  cell  lines, 
Fig. S2 shows characterization of hFbh1 mutants, and Fig. S3 shows ef-
ficiency of RNAi-mediated knockdown of hFbh1 in BJ fibroblasts. Online 
supplemental  material  is  available  at  http://www.jcb.org/cgi/content/ 
full/jcb.200812138/DC1.
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